Food, Drugs, Healthcare, Life Sciences

The Department of Justice has launched the FOCUS Initiative to engage with data miners using artificial intelligence and machine learning tools to identify False Claims Act violations. This initiative aims to strengthen partnerships with sophisticated data analysts while potentially signaling increased scrutiny of less rigorous data-based claims. Companies receiving federal funds should consider how these evolving enforcement capabilities impact their compliance strategies and risk management approaches.

This comprehensive legal update examines critical developments affecting the life sciences industry, including the surge in trade secret litigation, heightened scrutiny of employer health plan administration...

For the remainder of the 119th Congress – and into the 120th Congress if Democrats gain control of one or both chambers – the healthcare industry should expect sustained congressional investigations across a broad...

The U.S. Food and Drug Administration’s (FDA) Office of Dietary Supplement Programs (ODSP) recently held a public meeting to solicit input from stakeholders on how the Agency should regulate...

This comprehensive legal update examines critical developments affecting the life sciences industry, including the surge in trade secret litigation, heightened scrutiny of employer health plan administration...

Recent developments suggest that major health care and life sciences organizations are expanding their use of AI beyond trial initiatives and targeted applications, while federal and state...

The U.S. Food and Drug Administration’s (FDA) Office of Dietary Supplement Programs (ODSP) recently held a public meeting to solicit input from stakeholders on how the Agency should regulate...

Significant revisions to the Maine Substance Use Testing Law, 26 Maine Rev. Stat. 681 et seq., will take effect on July 29, 2026. Maine House Bill 1425 (2025-2026).

For the remainder of the 119th Congress – and into the 120th Congress if Democrats gain control of one or both chambers – the healthcare industry should expect sustained congressional investigations across a broad...